109
References.
1. Gafforov, Sunnatullo A., et al."Clinical characteristics and diagnosis of
chronic generalized periodontitis in patients with connective tissue dysplasia."
Russian Journal of Dentistry 26.3 (2022): 219-228.
2. Усманова, Шайра Равшанбековна, and Абдугаффур Ахатович
Хаджиметов. "Патогенетические особенности течения генерализованного
пародонтита у пациентов с хроническим
нарушением мозгового
кровообращения." Казанский медицинский журнал 97.5 (2016): 720-723.
THE USE OF A DRUG BASED ON HYALURONIC ACID IN THE
COMPLEX TREATMENT OF PERIODONTAL DISEASES
Batirov B. А., Shokirova F.F., Sofieva N.B., Murodov X.U.
Tashkent State Dental Institute, Uzbekistan
Introduction.
The use of a drug based on hyaluronic acid in the complex
treatment of periodontal diseases. Inflammatory and destructive periodontal diseases
occupy a leading place in the structure of dental morbidity (Grudyanov A. I.,
Fomenko E. V., 2010). According to the world health organization, functional
disorders of the dental system caused by the loss of teeth from periodontal diseases
develop almost 5 times more often than with complicated caries [1].
The high prevalence and intensity of periodontal diseases, premature loss of
teeth, decreased performance, violation of the psycho-emotional sphere, along with
the appearance of foci of conditioned diseases in the div and, not always, the high
effectiveness of treatment with a variety of medications, encourage further search
for the most effective medications in the complex therapy of this pathology [2]. The
leading direction in the development of methods for the treatment of inflammatory
and destructive periodontal diseases is local anti-inflammatory, antimicrobial
therapy with the creation of conditions for the restoration of destroyed periodontal
structures. Among the local medications
actions give preference to those that can be kept in the pocket for a long time,
having a therapeutic effect. In this regard, preparations based on hyaluronic acid
with the inclusion of antibacterial agents are of interest [3].
Purpose.
The aim of the work was to conduct a clinical and laboratory study
of the effectiveness of the drug based on hyaluronic acid in the complex treatment
of periodontitis.
Materials and methods.
We examined and treated 39 patients (20 men and
19 women aged 25 to 55 years) with chronic generalized periodontitis of mild and
moderate severity, whose complex therapy included a drug based on hyaluronic acid
(the main group). The control group was a group of patients of the same age with a
similar diagnosis who received traditional treatment (control group) [4]. The results
of treatment were evaluated according to the data of clinical research methods in
dynamics: examination, determination of the depth of periodontal pockets, the
Fedorov-Volodkina hygiene index (IG), the PMA index, the Shiller-Pisarev test, the
110
bleeding index (IC). Prior to treatment, all patients underwent oral sanitation and
were given recommendations on oral hygiene. After preliminary antiseptic
treatment, the above-and subgingival dental deposits were removed with a
piezoelectric sclera and curettage of periodontal pockets was performed [5].
Results.
Treatment of patients with the use of a drug based on hyaluronic acid,
allowed for a short period of time (6-8 visits in the main group against 10-12 visits
in the control group) to obtain a stable therapeutic effect. Clinical improvement was
confirmed by positive dynamics of clinical indices (table.1).
The dynamics of clinical indicators 7 days after treatment with a drug based
on hyaluronic acid indicated an improvement in the condition of periodontal tissues,
which was manifested by a decrease in inflammatory processes in the gums. 6
months after treatment, there was a significant decrease in the depth of periodontal
pockets, the disappearance of an inflammatory reaction in the gum.
Conclusions.
The preparation based on hyaluronic acid allows for a short
period of time (6-8 visits) to effectively affect the main pathogenetic mechanisms of
periodontitis development, to obtain a stable therapeutic effect. The drug based on
hyaluronic acid is convenient for use, well tolerated by patients, has no side effects
and contraindications to use, which allows us to recommend it for the complex
treatment of chronic generalized periodontitis [6].
References.
1.
Ivanov V.S.Zabolevaniya parodonta.-M.,1998.-296s.
2.
Kirsanov
A.I.,Orekhova
L.Yu.
,Gorbacheva
I.A.i
dr.Izuchenie
vzaimosvyazi
zabolevaniy
parodonta
s
obshchim
sostoyaniem
organizma//Parodontologiya.-1996.- №2.-S.-41-42
3.
Kankanyan A.P.,Leont'ev V.K.Bolezni parodonta:Novye podkhody v
etiologii,patogeneze,diagnostike,profilaktike i lechenii.-Erevan:Tigran Mets,1998.-
360s.
4.
Tsepov L.M.,Nikolaev A.I.,Mikheeva E.A.,Novikov V.I.Osobennosti
patogeneza vospalitel'nykh zabolevaniy parodonta i vrachebnoy taktiki pri
sakharnom diabete.//Parodontologiya.-2002.-№3.-S.15-21
5.
Barer G.M.,Lemetskaya T.I.Sovremennye tendentsii vybora metodov
lecheniya bol'nykh s patologiey parodonta.Sbornik tezisov nauchnogo foruma
«Stomatologiya na poroge tret'ego tysyacheletiya»6-9 fevralya 2001
goda.Moskva,2001.-S.-133-134
6.
Kuryakina
N.V.,Savel'eva
N.A.Stomatologiya
profilakticheskaya.M.,2003,288 s.
7. Eyayo, Faith. ’’Evaluation of occupational health hazards among oil
industry workers: A case study of refinery workers.” IOSR J Environ Sci 8 (2014):
2319-99.
8.Takhirova, Kamolakhon Abroro vna, and Khaydar Pazilovich Kamilov.
"Analysis of the state of microcirculation in patients with chronic generalized
parodontitis.” EUROPEAN RESEARCH: INNOVATION IN SCIENCE,
EDUCATION AND TECHNOLOGY. 2019.
